The inhibition of the USP8–GPX4 axis promoted ferroptosis and enhanced CD8+ T-cell infiltration, thereby improving the efficacy of anti-PD-1 immunotherapy in CRC (49). The gene discussed is GPX4; the disease is colorectal carcinoma.